Key facts
- It has raised $18.0M; the latest was Later Stage VC ($12.0M) in Aug 2025.
- Notable investors include Spectra Investments, Canary (Brazil), NXTP Ventures, Big Bets, Alexia Ventures — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Axenya
- ·The full record, as it builds
Funding rounds
No funding rounds for Axenya are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Axenya
Developer of a healthcare navigation platform designed to prevent, manage, or treat medical diseases and disorders. The company's platform provides a therapeutic program that allows healthcare providers to assist patients with disease management and also gives insights into patients' health and well-being, the system has features to generate disease-specific programs and patient data collection, enabling corporate clients and their employees by integrating cutting-edge software, state-of-the-art technology, and humanized support.
- Sector
- Healthcare
- HQ
- Sao Paulo, Brazil
- Founded
- 2020
- Employees
- 81
- Website
- axenya.com/
- Ownership
- Privately Held (backing)
Axenya doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Axenya shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Axenya in its N-PORT filings yet. We sweep new filings monthly.